A Prospective Single Centre, Single Arm, Open Label Study of the Long Term Use of a LHRA Agonist (Decapeptyl SR, 11.25mg) in Combination With Livial Add Back Therapy in the Management of Chronic Cyclical Pelvic Pain in Pre Menopausal Women.

Trial Profile

A Prospective Single Centre, Single Arm, Open Label Study of the Long Term Use of a LHRA Agonist (Decapeptyl SR, 11.25mg) in Combination With Livial Add Back Therapy in the Management of Chronic Cyclical Pelvic Pain in Pre Menopausal Women.

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Oct 2016

At a glance

  • Drugs Tibolone; Triptorelin
  • Indications Dysmenorrhoea
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Oct 2016 Status changed from recruiting to completed.
    • 03 Mar 2009 Actual initiation date (Dec 2008) added as reported by ClinicalTrials.gov.
    • 03 Mar 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top